Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Pfizer
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Eli Lilly and Company
OncoNano Medicine, Inc.